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INTRODUCTION
Excitatory amino acids act on the CNS through various
receptors, which are classified into two groups: ionotrop-
ic and metabotropic. Ionotropic receptors act on cationic-
specific ion channels and comprise N-metyl-D-asparate
(NMDA), alpha-amino-3-hydroxy-5-methylisoxazole-4-
propionate (AMPA), and kainate (KA) receptors
(V a r j u et al., 2001). Mammals possess six NMDA
receptor subunits, four AMPA receptor subunits and five
KA receptor subunits (J a n s s e n s et al., 2001).  Kainic
acid (KA), a pyrrolidine excitotoxin isolated from the
seaweed Digenea simplex, acts on glutamate receptors,
which leads to neurotoxic damage resembling the alter-
ations observed in some neurological disorders
(C a n d e l a r i o – J a l i l et al., 2001). Glutamate recep-
tors are the primary excitatory neurotransmitter receptors
in the vertebrate brain and are of critical importance to a
wide variety of neurological processes. Recent reports
suggest that ionotropic glutamate receptors may have a
unique transmembrane topology not shared by other lig-
and-gated ion channels. The ionotropic receptors open a
cationic channel that allows the passage of Na+, K+, and
Ca2+. Neocortical AMPA and KA receptors show little
permeability to Ca2+, except in the case of a subpopula-
tion of interneurons. The NMDA receptor, in addition to
allowing passage of Na+ and K+, is the main calcium
ionophore of the cerebral cortex. This receptor differs
from the other glutamate receptors by being both ligand-
gated and voltage sensitive (K a c z m a r e k et al., 1997).
Stimulation of glutamate KA receptors induces neu-
ronal nitric oxide (NO) release, which in turn modulates
glutamate transmission (A l a b a d i et al.1999;
N a k a k i et al., 2000). Nitric oxide is a highly reactive
signal molecule in the CNS. It is a unique messenger
molecule that serves diverse physiological functions
throughout the body. Nitric oxide is synthesized from L-
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arginine by nitric oxide synthase (NOS). The agent is a
gaseous chemical messenger that acts on interneuronal
communications, synaptic plasticity, memory formation,
receptor function, intracellular signal transmission and
mediator release (B r o w n et al., 1999; H e a l e s et al.,
1999; L e i et al., 1999). However, pathological condi-
tions may occur when higher fluxes of these mediators
are generated, such as during the process referred to as
excitotoxicity, i.e., the excessive activation of glutamate
KA receptors. This is a condition common to both acute
and chronic neurological diseases (S a n g p i e l et al.,
1998; B r o r s o n et al., 1999; C i r i o l o et al., 2001).
Excitotoxicity produced by glutamate is initiated by a
sustained increase of intracellular Ca2+. Influx of Ca2+
serves as a signal for activation of Ca2+-calmodulin
dependent and protein kinase C-regulated NOS.
Activation of NOS generates NO, which can produce
oxidative damage. In addition, elevated cytosolic free
Ca2+ can activate phospholipase A2, leading to subse-
quent generation of arachidonic acid. Metabolism of
arachidonic acid can than produce free reactive oxygen
species (ROS) and lipid peroxidation (P a t e l et al.,
2003). Because NO is a reactive free radical, it has many
potential targets to initiate neurotoxic cascades. It is well
known that NO toxicity may be amplified by the presence
of superoxide radical, the one-electron reduction product
of oxygen, since these species react at a diffusion-limited
rate to form peroxynitrite, a potent oxidant. Thus, oxida-
tive stress plays a critical role in excitotoxicity
(G u n a s e k a r et al., 1995). 
In view of the above, the present study was under-
taken to examine whether the production of NO after
receipt of intracerebral KA injections can be modulated
by pretreatment with competitive glutamate receptor
antagonists; namely, CNQX, a selective AMPA/KA
receptor antagonist; and APV, a selective NMDA recep-
tor antagonist. 
MATERIALS AND METHODS
Animals
Adult rats of the Wistar strain (Rattus norvegicus) of
both sexes, with body weight 200 ± 30 g, were used for
experiments. Groups of two or three rats per cage (Erath,
FRG) were housed in an air-conditioned room at room
temperature of 23 ± 2 °C with 55 ± 10% humidity and
lights on 12 h/day (07.00-19.00). The animals were given
a commercial rat food and tap water ad libitum. These
animals were anesthetized by giving intraperitoneal
injections of pentobarbital sodium (0.0405 g/kg b.w.) and
placed in a stereotaxic frame.
Experimental procedure and intracerebral injection of
drugs
The rats were divided into five basic groups (drug-
treated: KA, KA+CNQX, and KA+APV; and control:
intact and sham-operated animals), each basic group con-
sisting of five different subgroups (according to survival
times) of eight animals each. The drug-treated, groups
received a unilateral injection of antagonist: only KA
(Sigma Chemical Co. U.S.A., 0.5 mg/ml, dissolved in 0.1
M saline, pH 7.2; 1 mL total volume); KA plus CNQX
(Wak-Chemie Medical GMBH, Tocris, 0.5 mg/ml, dis-
solved in DMSO, pH 7.2; 1 mL total volume); and KA
plus APV (Sigma Chemical Co. U.S.A., 0.5 mg/ml, dis-
solved in 0.1 M saline, pH 7.2; 1 mL total volume) into
the CA3 region of the hippocampus (coordinates from
bregma: anteroposterior: -3.3 mm, dorsoventral: 3.2 mm,
and lateral: 3.0 mm) using a Hamilton microsyringe with
a beveled tip. The control group received the same vol-
ume (1 mL) but only saline solution (sham-operated),
white the group of intact animals served as a control for
mechanical injection. The animals were allowed to sur-
vive for 5 min to seven days (5 min, 15 min, 2 h, 48 h and
7 days). All animals were anesthetized and decapitated,
after which the brains were immediately removed. The
ipsi- and contralateral hippocampus, forebrain cortex,
striatum, and cerebellum from individual animals were
quickly isolated and homogenized in ice-cold buffer con-
taining 0.25 M sucrose, 0.1 mM EDTA, and 50 mM K-
Na phosphate buffer, pH 7.2. Homogenates were cen-
trifuged twice at 1580g for 15 min at 4°C. The super-
natant obtained by this procedure was then frozen and
stored at -70°C.
Nitrite measurement 
Nitrite and nitrate determinations in biological
material are increasingly being used as markers of NO
production. We detected nitrite in the rat brain
homogenates by the Griess method (G u e v a r a et al.,
1998). Nitric oxide production was quantified by measur-
ing nitrite, a stable oxidation end product of NO
(G r e e n et al., 1982). Briefly, nitrite production was
determined by mixing 50 mL of the assay buffer with 50
mL of Griess reagent [1.5 % sulfanilamide in 1 M HCl
plus 0.15 % N-(1-naphthyl) ethylenediamine dihy-
drochloride in distilled water, v:v]. After 10 min of incu-
LIDIJA RADENOVIĆ ET AL.30
bation at room temperature, the absorbance at 540 nm
was determined and nitrite concentrations were calculat-
ed from the sodium nitrite (Sigma) standard curve. All
measurements were performed in triplicate.
Protein concentration measurement
The content of protein in rat brain homogenates
(hippocampus, striatum, forebrain cortex, and cerebel-
lum, ipsilateral and contralateral) was measured by the
Lowry method (L o w r y et al., 1951) using bovine serum
albumin (Sigma) as standard. All measurements were
performed in triplicate. 
Materials
Chemicals were purchased from Sigma (St. Louis,
MO, U.S.A.). Other chemicals were of analytical grade.
All drug solutions were prepared on the day of the exper-
iment. Animals used for procedures were treated in strict
accordance with the Ethical Committee of the Serbian
Association for Animal Science (SLASA).
Data presentation and analysis
All experiments were done with n = 8. Each assay
was performed at least twice under identical conditions.
Data are expressed as means ±SD. The statistical signifi-
cance of differences between groups was assessed by
Student’s t-test (paired and unpaired) for individual com-
parisons and regression analysis for overall significance
(with p < 0.05 as significant and p < 0.01 as very signif-
icant).
RESULTS
The results presented in Figs. 1-4 show the nitrite
levels (mM/mg proteins) in hippocampal, cortical, stria-
tal, and cerebellar homogenates, respectively. Compari-
son of nitrite levels in the intact group and sham-operat-
ed animals shows the effect of mechanical injection in rat
brain. There was no significant difference between nitrite
levels in these two groups. This means that mechanical
injection only is not sufficient to trigger oxidative stress
and/or excitotoxicity. We therefore used sham-operated
animals as controls. In the control group, nitrite levels
showed no significant differences between the left and
right hemispheres in only of the tested structures. Also,
there was no significant difference between mean nitrite
levels obtained from each hemisphere after antagonist
treatment in any of the tested brain structures, although
the injection site was in the ipsilateral hippocampus. 
Intrahippocampal KA injection resulted in generally
higher levels (according to the Student t-test; p<0.05) of
nitrite production in all tested brain structures. The
obtained levels of nitrite production were highest in the
hippocampus (Fig. 1). Rapid increase in nitrite produc-
tion was found at 5 min after KA injection and these
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0
4
8
12
16
5 min. 15 min. 2 h 48 h 7 days
m
M
 n
itr
ite
 / 
m
g 
pr
ot
.
intact control KA KA+CNQX KA+APV
à à à à
à¿
à¿
à
à à à
à à à
à
à
Fig. 1. Effect of intrahippocampal injection of kainate (KA), kainate
plus APV (KA+APV), and kainate plus CNQX (KA+CNQX) on nitrite
levels (mM NO-2/mg prot.) in the rat hippocampus at different survival
times. Data are means ± S.D. * and ** indicate statistically significant
(p<0.05) and very significant (p<0.01) differences between glutamate
antagonist-treated and control (sham-operated) animals. * and ** indi-
cate statistically significant (p<0.05) and very significant (p<0.01) dif-
ferences between glutamate antagonist-treated and KA-treated animals.
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Fig. 2. Effect of intrahippocampal injection of kainate (KA), kainate
plus APV (KA+APV) and kainate plus CNQX (KA+CNQX) on nitrite
levels (mM NO-2/mg prot.) in the rat forebrain cortex at different sur-
vival times. Data are means ± S.D. * and ** indicate statistically signif-
icant (p<0.05) and very significant (p<0.01) difference between gluta-
mate antagonists treated and control (sham-operated) animals. * and **
indicate statistically significant (p<0.05) and very significant (p<0.01)
difference between glutamate antagonists treated and KA-treated ani-
mals. 
higher levels continued to be above normal at all tested
times (with 7 days as the final time point) in all tested
brain structures (Figs. 1-4). At 5 min after KA injection,
nitrite measurements in the hippocampus (12.76 ± 1.63
mM NBT/mg protein), in the forebrain cortex (11.45 ±
1.00 mM NBT/mg protein), in the striatum (12.56 ± 1.34
mM NBT/mg protein) and in the cerebellum (12.26 ±
1.00 mM NBT/mg protein) showed statistically very sig-
nificant differences (p<0.01) compared with the equiva-
lent control group (Figs. 1-4). The results obtained for the
contralateral hippocampus, forebrain cortex, striatum and
cerebellum were similar (data not presented).
Intrahippocampal KA plus CNQX injection resulted
in a reduction of nitrite levels back to control values in all
tested brain structures (Figs.1-4). Thus, there was a sig-
nificant decrease in nitrite levels only in comparison to
KA-treated animals (p<0.05). Analogous to the excito-
toxic effect obtained with KA-injected animals, statisti-
cally the most significant decrease was obtained at 5 min
(6.74 ± 1.83 mM NBT/mg protein in the hippocampus,
7.07 ± 1.33 mM NBT/mg protein in the forebrain cortex,
7.03 ± 1.11 mM NBT/mg protein in the striatum and 7.61
± 1.29 mM NBT/mg protein in the cerebellum, p<0.01;
Figs. 1-4). 
Intrahippocampal KA plus APV injection resulted in
decrease of nitrite levels in all tested brain structures as
compared with the equivalent group of KA-treated ani-
mals, but with different time dynamics (Figs.1-4). The
effect of this antagonist was interesting because at 5 min
from injection, nitrite levels in all tested brain structures
were still high in comparison with the control group
(12.28 ± 1.00 mM NBT/mg protein in the hippocampus,
9.87 ± 1.16 mM NBT/mg protein in the forebrain cortex,
9.89 ± 1.50 mM NBT/mg protein in the striatum, and
10.96 ± 1.17 mM NBT/mg protein in the cerebellum,
p<0.05; Figs.1-4). 
DISCUSSION
The role of NO in cerebral insult remains controver-
sial. While numerous studies have used ischemia, hypox-
ia and status epilepticus models, few have examined NO
in the KA model of excitotoxicity. Animals exposed to
KA-induced status epilepticus display a striking pattern
of selective neuronal vulnerability in the hippocampus.
Neurons in the hilus/CA3 and CA1 subfields appear par-
ticularly sensitive, whereas dendate gyrus granule cells
are resistant (B e c k e r et al., 1999; L e r e et al., 2002),
which is likely due to the high concentration of KA
receptors on their membranes. Regional distribution of
NMDA and AMPA/KA receptors of the rat brain was
found to be highest in deep layers (layer 5) of the fore-
brain cortex, the cerebellar granule cell layer, and the
caudate putamen (C a  r r o l l et al., 1998; B a i l e y et
al., 2001), which is why we tested these particular brain
regions: hippocampus, forebrain cortex, striatum, and
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Fig. 3. Effect of intrahippocampal injection of kainate (KA), kainate
plus APV (KA+APV), and kainate plus CNQX (KA+CNQX) on nitrite
levels (mM NO-2/mg prot.) in the rat striatum at different survival times.
Data are means ± S.D. * and ** indicate statistically significant
(p<0.05) and very significant (p<0.01) differences between glutamate
antagonist-treated and control (sham-operated) animals. * and ** indi-
cate statistically significant (p<0.05) and very significant (p<0.01) dif-
ferences between glutamate antagonist-treated and KA-treated animals.
Nitrite levels in rat cerebellum
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Fig. 4. Effect of intrahippocampal injection of kainate (KA), kainate
plus APV (KA+APV), and kainate plus CNQX (KA+CNQX) on nitrite
levels (mM NO-2/mg prot.) in the rat cerebellum at different survival
times. Data are means ± S.D. * and ** indicate statistically significant
(p<0.05) and very significant (p<0.01) differences between glutamate
antagonist-treated and control (sham-operated) animals. * and ** indi-
cate statistically significant (p<0.05) and very significant (p<0.01) dif-
ferences between glutamate antagonist-treated and KA-treated animals.
cerebellum.
In the present study, an appropriate dose of KA (0.5
mg/ml) was used to cause slight brain damage in the ipsi-
lateral, but not contralateral, hippocampus; there were no
behavioral or epileptic effects. It was previously shown
that NO formation occurs in different regions of the rat
brain during KA-induced seizures (M u l s c h et al.,
1994; Y a s u d a et al., 2001). In our experiments, nitrite
levels were measured at various times following intrahip-
pocampal KA injection in the above-indicated four rat
brain structures. Cortical areas such as the pyriform and
entorhinal cortices are known to contain the highest pack-
ing densities of nNOS-positive interneurones
(B i d m o n et al., 1999), suggesting that neurotransmis-
sion and probably cognitive information processing in
normal animals would be affected by the pharmacologi-
cal modulation of NO production. 
We have shown that NO end-product levels in the
rat brain increased immediately after KA injection and
continued to increase gradually throughout the experi-
ments. Under conditions of normal behavior in the rat,
the damage was localized mainly in the CA3 region of
hippocampus, where neuronal loss occurred.
Agonist-triggered Ca2+ influx may constitute a key
link between glutamate receptor activation and subse-
quent neurodegeneration. In cortical culture, brief peri-
ods of activation of NMDA channels, which are highly
Ca2+-permeable are capable of triggering widespread
neurodegeneration. In contrast, much more prolonged
periods of activation of AMPA/KA receptor-gated chan-
nels are required before comparable neurotoxicity devel-
ops. This may reflect the fact that most AMPA/KA chan-
nels are poorly permeable to Ca2+ and likely cause sec-
ondary Ca2+ influx via the depolarization and activation
of voltage-sensitive Ca2+ channels. Multiple factors have
been hypothesized to contribute to the differences in tox-
icity that result from NMDA and AMPA/KA receptor
activation (C a r r i e d o et al., 1996; N i c h o l l s et al.,
2000).
In this study, we detected different effects of the
NMDA antagonist APV and the AMPA/KA antagonist
CNQX on nitrite levels after intrahippocampal injection
with KA. The effect of KA on nitrite production was
blocked by the glutamate antagonists. Intrahippocampal
injection of KA plus CNQX resulted in decrease of nitrite
production to around control levels in all tested brain
structures. Thus, significant decrease in nitrite levels was
found only in comparison to KA treated animals, i.e., the
overall effect of a selective AMPA/KA receptor antago-
nist was a decrease of KA-induced excitotoxicity. The
accent effect of intrahippocampal injection of KA plus
APV also resulted in decrease of nitrite production.
However, this effect was detected 15 min after injection,
suggesting the existence of an NMDA receptor-mediated
component of basal nitrite production in physiological
conditions and differences of mechanisms and time
dynamics between CNQX and APV. The used glutamate
receptor antagonists of showed the same pattern in all
tested brain structures.
From the data presented, it is obvious that increase
of nitrite levels in KA-induced neurotoxicity is not
dependent on activation of only one class of ionotropic
glutamate receptors. We hypothesize that by selectively
blocking AMPA receptors with CNQX, we reduced
nitrite production but did not inhibit several other cellu-
lar pathways of NO generation (H a l a s z et al., 2004).
A possible explanation is that KA enhances hippocampal
NO generation (K a s h i k a r a et al., 1998), while KA
injection results in differential regulation of nNOS
mRNA and NO formation in the rat hippocampus (K a s
h i k a r a et al., 2000). It was previously reported that
inhibition of nNOS by 7-nitroindazole can effectively
lower NO production at early testing times (from 5 min
to 2 h) in the rat brain following intracerebral KA injec-
tion (R a d e n o v i ć et al., 2003). 
Published results implicate neuronal NO generation
in the pathogenesis of both direct and secondary excito-
toxic neuronal injuries in vivo. The precise cellular mech-
anisms that lead to neurotoxicity under these conditions
still remain unclear. Although NMDA receptors likely
contribute critically to neuronal injury in various acute
conditions, several observations support the hypothesis
that AMPA/KA receptors may be of greater importance to
the neurodegenerative process (C a r r i e d o et al., 1998,
2000). Considerable evidence supports a link between
Ca2+ influx and glutamate receptor-mediated neurode-
generation. Brief periods of activation of highly Ca2+-
permeable NMDA channels can result in substantial
intracellular Ca2+ accumulation and widespread neuronal
injury (H y r c et al., 1997; L u et al., 1996; T s e n g et
al., 2003). Mitochondria can buffer these large Ca2+ loads
but they do so at the expense of triggering injurious ROS
production (P e n g et al., 1998). Additionally, the
extremely rapid interconversion of ROS within the cell
can make it difficult to identify the originating species.
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We previously reported differential roles of NMDA and
AMPA/KA receptors in superoxide production and mito-
chondrial MnSOD activity in the rat brain (R a d e n -
o v i ć et al., 2004). 
In contrast to NMDA receptors, AMPA/KA recep-
tors are generally Ca2+ -impermeable and trigger injury
more slowly, with prolonged periods of activation need-
ed before significant neuronal injury occurs (K o h et al.,
1990). Subpopulations of central neurons, however, are
highly vulnerable to AMPA/KA receptor-mediated injury,
likely attributable in part to the existence of large num-
bers of AMPA/KA channels with high Ca2+ permeability
(W e i s s et al., 2001). 
The used glutamate antagonists APV and CNQX
both provided sufficient neuroprotection in sense of
decreasing nitrite levels, but with different mechanisms
and time dynamics.
In conclusion, the increase of NO production in dis-
tinct brain regions functionally connected via afferents
and efferents suggests that these regions are affected by
the injury. Furthermore, the data point to differential roles
of NMDA and AMPA/KA receptors during this neu-
ropathological condition. 
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Стимулација глутаматских рецептора доводи до ства-
рања азот оксида (NO) у неуронима мозга што дово-
ди до модулације глутаматске неуротрансмисије. Ис-
питивана је улога глутаматских NMDA и AMPA/каи-
ЕФЕКАТ АНТАГОНИСТА ГЛУТАМАТА НА СТВАРАЊЕ АЗОТ ОКСИДА 
У МОЗГУ ПАЦОВА
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натних рецептора у стварању NO у мозгу пацова пос-
ле интрацеребралне апликација каината, агониста
AMPA/каинатних рецептора,  каината са 6-циано-7-
нитрокиноксалин-2,3-дионом (CNQX), селективним
антагонистомAMPA/каинатних рецептора или каина-
та са 2-амино-5-фосфонопентаноиском киселином
(APV) селективним антагонистом NMDA рецептора.
Антагонисти глутамата су аплицирани унилатерално
у селективно осетљив CA3 регион хипокампуса.
Стварање NO је праћено преко акумулације нитрита,
стабилних метаболита NO, Griess-овом методом.
Мерења су вршена у хипокампусу, кортексу, стиату-
му и церебелуму мозга пацова 5 min, 15 min, 2 х, 48 х
и 7 дана након апликације. У свим праћеним можда-
ним структурама неуропротективно је деловала при-
мена CNQX и APV у смислу смањења продукције
NO, али са очигледном разликом у механизму дејства
и временској динамици. Резултати нашег истражива-
ња доказују да су глутаматски NMDA и AMPA/каи-
натни рецептори различито укључени у процес про-
дукције NO. 
Кључне речи: APV, CNQX, ексцитотоксичност, каи-
нат, неуропротекција, оксидативни стресс, нитрите,
NO.
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